Table 5.
Comparison of mean and median survival time after adjuvant chemotherapy between the PSC and NSCLC cohorts.
| Groups | Chemotherapy | Mean OS (months) | 95%CI | Median OS (months) | 95%CI |
|---|---|---|---|---|---|
| PLS | No | 21.990 | 16.982 – 27.000 | 3 | 2.298 – 3.702 |
| Yes | 19.921 | 13.918 – 25.924 | 8 | 6.805 – 9.195 | |
| Overall | 21.549 | 17.536 – 25.562 | 4 | 3.034 – 4.966 | |
| Adjusted NSCLC | No | 27.886 | 22.343 – 33.428 | 7 | 4.929 – 9.071 |
| Yes | 30.793 | 24.974 – 36.612 | 15 | 12.329 – 17.671 | |
| Overall | 29.913 | 25.668 – 34.159 | 11 | 8.698 – 13.302 |
PSC, pulmonary sarcomatoid carcinoma; NSCLC, non-small cell lung cancer; OS, overall survival; CI, confidence interval.